Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer

  • Technology appraisal guidance
  • TA611
  • Published: 

This guidance has been updated and replaced by NICE technology appraisal guidance TA1007.